We are pleased to announce that HRV Pharma' strategic participation at DCAT Week 2025 in New York has received extensive media coverage across multiple leading pharmaceutical and business publications.
Our company's successful engagements during this prestigious industry event, which took place from March 3-6, 2025, have been highlighted by numerous media outlets, showcasing our commitment to global expansion and pharmaceutical innovation.
"Our participation at DCAT Week 2025 represents a critical step in our global growth strategy. The connections and partnerships we've established here will drive significant advancements in our mission to deliver innovative pharmaceutical solutions to global markets."
Mr. Hari Kiran Chereddi, Managing Director of HRV Pharma
Media Coverage
Our participation at DCAT Week 2025 has been widely covered by leading pharmaceutical and business publications:
- Pharmabiz
- The Pharma Times
- BioVoice News
- MediCircle
- News Patrolling
- APN News
- India Education Diary
- Tripura Star News
- Business News This Week
- Business News Matters
Looking Ahead
As we continue to expand our global footprint, HRV Pharma remains committed to our core values of innovation, quality, and accessibility. The connections established during DCAT Week 2025 are expected to translate into strategic partnerships that will further enhance our ability to meet the evolving needs of patients and healthcare providers worldwide.
For more information about our innovative pharmaceutical solutions, please contact us or explore our product portfolio.
